Stress hormone secretion and gut signal transducer (STAT) proteins after burn injury in rats. by Thellin, Olivier et al.
Published in: Shock (2001), vol. 16, iss. 5, pp. 393-397. 
Status: Postprint (Author’s version) 
 
STRESS HORMONE SECRETION AND GUT SIGNAL TRANSDUCER 
(STAT) PROTEINS AFTER BURN INJURY IN RATS 
 




 Cora K. Ogle,
†
 and Nelson D. Horseman*
†
 
*Department of Molecular and Cellular Physiology, University of Cincinnati 
†Shriners Hospital for Children 
‡Department of Cell Biology, Neurobiology, and Anatomy, University of Cincinnati, Cincinnati, Ohio 45267 
 
ABSTRACT  
A burn injury triggers traumatic reactions characteristic of a stress. Here we investigated the early responses of 
prolactin (PRL), corticosterone (CS), and signal transducer and activator of transcription 5 (STAT5) in male 
Sprague-Dawley rats after burn injury. PRL and CS levels were determined in blood serum. STAT5 and 
phospho-STAT5 levels were determined in jejunum total protein extracts. The results confirmed an expected 
increase of CS between 4 and 6 h after the burn injury. Unexpectedly, PRL secretion was suppressed during the 
same time frame. These hormone levels returned to normal 6 to 8 h after burn injury. STAT5 was increased in 
the jejunum after burn injury, and its phosphorylation was increased between 8 and 11 h after burn injury. These 
changes in STAT5 were not temporally correlated with either the hormone changes that we observed or with 
previously documented changes of the gut function after burns. 
KEYWORDS : Glucocorticoids ; prolactin ; STAT5 ; radioimmunoassay 
 
INTRODUCTION 
Λ burn injury is a physiological stress that provokes traumatic reactions at both systemic and tissue levels (1-4). 
The first and immediately most important effect is located at the burn site itself and is due to the reaction of 
living tissues to the heat, in the case of thermal burn, or chemicals, in the case of chemical burns. Neurally 
mediated effects, such as pain and a psychological shock status, happen simultaneously. Burn site-generated 
molecular products reach the blood circulation and spread systemically (5. 6). All these factors converge and 
trigger numerous systemic and local effects in tissues and organs that arc not directly affected by the burn. 
Meaningful examples of' these target organs are the pituitary gland, the adrenal glands, and the gut. Each of 
them, affected by the burn-generated systemic reaction, is a source of hormones and cytokines that affect other 
important aspects of the post-burn physiology, contributing to the burn-generated trauma at both systemic and 
local levels. 
The pituitary gland responds to physiological stresses by altered secretion of prolactin (PRL), growth hormone 
(GH), and adenocorticotrophic hormone (ACTH) (7, 8). PRL and GH may be immunostimulatory (9). In 
contrast, the adrenal glands are the main secreting organs for immunosuppressing glucocorticoids (GC), under 
the control of pituitary-derived ACTH. Gut cells (macrophages and enterocytes) produce inlerleukin-6 (IL-6), 
and ils production is significantly increased shortly after thermal injury (10). This proinflammatory cytokine is 
known to act, as GH and PRL, through a Jak2-STAT5 (Janus kinase 2: signal transducer and activator of 
transcription 5) intracellular pathway leading to a dimerization of phosphorylated STAT5, entry of the dimer in 
the nucleus, and binding of the dimer to GAS (gamma activation sites) response elements triggering specific 
gene expression (11). Glucocorticoid receptor (GC-R) also binds STAT5 and acts as coactivator of STAT5-
related signal transduction (12 for review). Reciprocally. STAT5 reduces GC-R effectiveness, leading to 
reduction of GC-mediated gene induction (13). STAT5 phosphorylation can also be activated by numerous 
soluble factors (e.g., IL-3, 1L-7, granulocyte macrophage colony-stimulating factor, or erythropoietin), and 
STATS is present in both hematopoietic and epithelial gut cells that are affected by burn injuries. Thus, STAT5 
may be a critical link between endocrine hormones and cytokine signaling. 
The integrity of the gut is compromised after a burn injury, allowing translocation of bacteria to the interstitium 
and circulation, contributing to septicemia (14). The profound reactions in the gut after burn injuries imply a role 
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for stress-induced endocrine factors in this gut response, and PRL/GH receptors are present in the gut (15, 16). 
Consequently, GH, PRL. and other molecules, such as IL-6 or glucocorticoids, could play an active role in these 
phenomena. 
Anabolic hormones such as GH or PRL have been suggested to improve the current clinical protocols used after 
a burn injury. Indeed, the results of several studies suggest that a GH treatment can help to reduce the mortality 
(17-20). PRL seems to help as a treatment of the immunodepression after hemorrhage (21. 22). But Alzeer et al. 
(7) showed that a high level of GH during the first 6 h after a burn injury was correlated with a lower patient 
survival ratio. This result is challenging because it is opposite to the proposed hypothesis that GH and PRL will 
improve patient outcomes. However, there are very few data regarding the pattern of pituitary hormone secretion 
during the first hours after a burn injury, which could help to explain such contradictions. Because PRL may 
have fewer undesirable side effects than GH the lack of information regarding PRL after traumas is a particularly 
important knowledge gap. 
Figure 1 summarizes the hypothesis we will test in this article. This hypothesis proposes that after burn injury, 
the pituitary synthesis and/or release of PRL and ACTH are increased, under the control of the hypothalamus 
and systemic regulators. ACTH increases the glucocorticoid secretion from the adrenal glands. The 
proinflammatory cytokine IL-6 production is increased in the gut, through a mechanism yet to be discovered. 
The increases of PRL, GC, and IL-6 synthesis are then integrated at the STAT5 phosphorylation levels in gut 
cells, and the resulting effect contributes to the loss of tissue integrity observed in gut after burn injury. In 
addition, IL-6 also plays an important role in the acute phase response, which includes a complex set of host 
reactions to prevent ongoing tissue damage and activate repair processes through changes in protein production 
by the liver and other organs (23). Some of these IL-6 actions are mediated by STAT5 (24). 
To help answer these questions, we have investigated in the present study the serum levels of corticosterone (CS) 
and PRL in male Sprague-Dawley rats during the first 24 h after burn injury, for which no data are available in 
the literature. To investigate if hormones could act directly through STAT5 on the enterocytes bordering the gut, 
we have also followed the variations of the amount of STAT5 and phosphorylated STAT5 in total protein 
extracts from gut cells during the 24 h after burn injury. 
 
FIG. 1. Working hypothesis. Burn injury increases ACTH and PRL secretion from the pituitary gland. ACTH 
increases GC secretion from the adrenal glands. Increase of IL-6 synthesis in the gut contributes to the acute 
phase response (thus synthesis of acute phase proteins, or APP) in the liver. Then PRL, GC, and IL-6 act on 
STAT5 synthesis and/or phosphorylation in the gut, which contribute to the loss of gut tissue integrity and could 
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MATERIALS AND METHODS 
Rat treatments and sample collecting 
Male Sprague-Dawley rats (Jackson Laboratories, Bar Harbor, MA), 250-300g. were adapted to a l2-h light (6 
a.m. to 6 p.m.)-l2-h darkness (6 p.m. to 6 a.m.) cycle during 1 week and then were divided into 3 groups: 1) no 
treatment and no handling before killing (control animals); 2) rats anesthetized and prepared for the burn but not 
burned (sham-treated animals); and 3) rats anesthetized and burned (burned animals). Water and food were 
provided ad libitum before and after the treatments. All experiments are performed according to the University 
of Cincinnati Institutional Animal Care and Use guidelines. All experiments adhered to the National Institutes of 
Health Guidelines for the Care and Use of Experimental Animals. 
The control animals were taken at specific times of the day (9:30 a.m., 12 p.m., 4 p.m.. and 7 p.m. ± 30 min) 
front the animal quarter and immediately killed by CO2 inhalation. Their abdomen and thorax were shaved and 
opened, and 1.4 mL of blood was obtained from the heart and placed on ice overnight. Blood serum was 
obtained after centrifugation (3000 g. 10 min, 4°C) and was stored at -20°C. The jejunum was isolated, its 
content was washed with saline and opened, and the internal face on the jejunum was harvested by scraping with 
a glass microscope slide. The tissue sample was then homogenized in standard RIPA buffer (in 100 ml PBS; 1 
mL NP40, 0.3 g Na deoxycholate, 0.1 g sodium dodecylsulfate. 1 ml, phenylmethylsulfonyl fluoride at 10 
mg/mL in isopropanol. 2.3 mL aprotinin at 2 mg/mL, 1 mL Na orthovanadate at 100 mM). Total jejunum protein 
extract was obtained after a 15-min centrifugation (13,000 g, 4°C) of the homogenale, and stored at -20°C. These 
control animals provided normal circadian cycle data. Four animals were used per condition. As controls for 
neutrophils and Mo/Ma detection, spleen cells were isolated after spleen grinding between frozen glass plates, 
bone marrow cells were harvested alter flushing of the femoral cavity, and CHO D6 cells were obtained from 
culture. Their total proteins were extracted by using RIPA buffer as described for the jejunum. Four animals 
were used per condition. 
The sham-treated animals were taken from the animal quarter at 7 a.m. They were anesthetized by pentobarbital 
(Abbott Laboratories. Abbott Park, IL) i.p. injections (first 2 mL of a 5 mg/mL solution in saline/kg, and then 
additional injections of 1 mL and 0.5 mL were administered when needed). When asleep, their back was shaved, 
and they received an i.p. injection of saline (100 mL/kg). At 8 a.m. (0 time point), the animals were placed on a 
metallic grid. The burn site, representing 25-30% of total body surface according to weight surface standards, 
was limited by wet tissues covering both of their sides, the limbs, and the shoulders, hut the animals were not 
burned. They recovered thereafter on a warming pad. The sham-treated animals were killed at specific times 
(±30 min) during day 1 (9:30 a.m., 12 p.m.. 4 p.m., and 7 p.m.) and day 2 (8 a.m.) after the sham treatment. 
Serum samples and jejunum protein extracts were obtained for each animal. Three animals were used per 
condition. 
The burned animals were handled exactly like the sham-treated rats, but for the burn itself. Briefly, they were 
removed from the animal quarter at 7 a.m. and anesthetized by using pentobarbital. Their back was shaved and 
saline was injected i.p. At 8 a.m. (0 lime point), they were placed on a metallic grid with the burning site limited 
by wet tissues. Kerosene-soaked gauze (cut to 25-30% of the total body surface area) was applied on the site and 
was allowed to burn for 30 s. This burn is a full-thickness third-degree burn. The rats recovered thereafter on a 
warming pad and were killed like the sham-treated animals at specific limes (±30 min) during day 1 (9:30 a.m., 
12 p.m., 4 p.m.. and 7 p.m.) and day 2 (8 a.m.) after the burn. Serum samples and jejunum whole-cell protein 
extracts were obtained for each animal. Three animals were used per condition. 
Cell line 
Chinese hamster ovary cells (CHO D6, an epithelial cell line) are maintained in Ham's F-12 culture medium 
supplemented by 10% fetal bovine serum, 100 U/ml. penicillin, 100 µg/mL streptomycin, 2 mM L-glutamine 
and 250 µg/mL G418 (Sigma, St. Louis, MO). 
Rat serum PRL 
The concentrations of prolactin in the blood sera were determined by a modified radioimmunoassay (RIA). Rat 
PRL (RP-3 from NIDDK, Bethesda. MD) was used as reference preparation. Briefly, serum aliquots were 
diluted in PBS containing 0.1 % BSA in opaque while 96-well plates (Packard, Meriden. CT) to a final volume 
of 100 µL. After adding 50 µL each of primary antibody and iodinated hormone, the plates were incubated for 2 
days at 4°C. Protein A (50 µL) was then added, and the plates were centrifugcd al 4000 g for 10min. The 
Published in: Shock (2001), vol. 16, iss. 5, pp. 393-397. 
Status: Postprint (Author’s version) 
 
supernatant was aspirated, and the pellet was dissolved in 20 µL of 0.1 N NaOH followed by 200 µL of 
scintillation fluid (Microscint 20. Packard). The plates were sealed with TopSeal (Packard), and after vigorous 
mixing, radioactivity was counted by using a Packard TopCount. 
Rat serum corticosterone 
The concentrations of corticosterone in the serum samples were determined by a commercial solid-phase RIA 
validated for the rat (Rat Corticosterone Coat-A-Count, Diagnostic Products. Los Angeles. CA). The analysis 
was performed by the Endocrinology Laboratory in the Diagnostic Laboratory, at the College of Veterinary 
Medicine, Cornell University. 
Rat jejunum cells STAT5 and phospho-STAT5 
The amount of STAT5 and phospho-STAT5 (pSTAT5) in the jejunum cell protein extracts were determined by 
Western blotting, The jejunum whole-cell protein extracts (15 µg) were resolved on 7% acrylamide gels by 
reducing sodium dodecyl sulfate-polyacrylamide gel eleclorphoresis (SDS-PAGE) along with a molecular 
weight marker (Bio-Rad Laboratories. Hercules, CA). followed by electrophoretic transfer to Protran 
nitrocellulose membranes (Schleicher and Schuell, Valley Park, MO). For STAT5, membranes were blocked by 
incubation for 30 min at room temperature with 5% nonfat milk in TBS-T (Tris-buffered saline-Tween: 20 mM 
Tris pH 7.5, 140 mM NaCl, 0.1% Tween-20). followed by 1-h incubation with rabbit anti-mouse STAT5h 
polyclonal antibody (N-20. able to bind both a and b forms of STAT5, from Santa Cruz Biotechnology. Santa 
Cruz, CA) 1:1000 in 5% milk and two 5-min washes in TBS-T. Blots were then incubated with 1:1000 of 
horseradish peroxidase-linked goal anti-rabbit IgG monoclonal antibody (Sigma), followed by two 5-min washes 
with TBS-T. 
For pSTAT5, membranes were blocked by incubation for 1 h at room temperature with 5% BSA in modified 
TBS-T (mTBS-T: 10 mM Tris pH 7.5, 50 mM NaCl, 0.1% Tween-20), followed by a 1-h incubation with rabbit 
anti-mouse pSTAT5 polyclonal antibody (Zymed, San Francisco, CA) 1:250 in 5% BSA and four 10-min 
washes in mTBS-T. Blots were then incubated with horseradish peroxidase-linked goat anti-rabbit IgG 
monoclonal antibody (Sigma) 1:1000 in mTBS-T, followed by four 10-min washes with mTBS-T. 
Enhanced chemiluminescence (ECL) detection was performed according to the manufacturer's (Amersham 
Pharmacia Biotech, Piscataway, NJ) specifications. Quantification of digitally scanned Western blots was 
performed by using the public domain NIH Image program (developed at the U.S. National Institutes of Health 
and available on the Internet at http://rsb.info.nih.gov/nih-image/). 
Rat jejunum cells Mo/Ma 
Jejunum monocytes/macrophages (Mo/Ma) invasion was investigated by Western blotting. The jejunum whole-
cell protein extracts (15 µg) were resolved on 7% acrylamide gels by reducing SDS-PAGE, followed by 
electrophoretic transfer to Protran nitrocellulose membranes. Membranes were blocked by incubation for 30 min 
at room temperature with 5% nonfat milk in TBS-T (20 mM Tris pH 7.5. 140 mM NaCl. 0.1% Tween-20), 
followed by a 1-h incubation with mouse anti-rat monocytes/macrophages monoclonal antibody (Biosource, 
Camarillo. CA) 1:400 in 5% milk and two 5-min washes in TBS-T, Blots were then incubated with 1:1000 of 
horseradish peroxidase-linked goal anti-mouse IgG polyclonal antibody (Cappel, Durham. NC), followed by two 
5-min washes with TBS-T. ECL detection was performed according to the manufacturer's specifications. 
Rat myeloperoxydase assay 
Jejunum neutrophil invasion was investigated by measuring tissue myeloperoxydase (MPO) levels. Jejunum cell 
protein extracts were obtained as described here before, and the MPO levels were measured by a 30-min H2O2-
dependent oxidation of 3,3',5,5'-tetramethylbenzidine (Sigma), which generates a blue colorimetric reaction 
shifted to yellow using H2SO4. Spectrophotometry absorbance was read at 450 nm and compared with a linear 
standard curse. 
Statistics 
Statistical analyses were performed by analysis of variance (ANOVA), with post hoc comparison among 
individual treatment means. Significance was defined as P < 0.05. 
Published in: Shock (2001), vol. 16, iss. 5, pp. 393-397. 
Status: Postprint (Author’s version) 
 
FIG. 2. Serum corticosterone (CS) levels. CTRL shows the normal CS circadian cycle in the blood. SHAM shows 
the effects of anesthesia and handling stress on the CS levels. BURN shows the effects of the burn injury on the 
CS levels. Statistically significant differences appear between each of the three treatments (CTRL, SHAM, and 
BURN: P < 0.01 ). BURN also significantly differs from SHAM at 12 p.m. (P < 0.05). Values represent the 
means ± SEM. **Differs from CTRL (P < 0.01); 
●
differs from SHAM (P < 0.05); 
●●
differs from SHAM (P < 
0.01). Bar: dark-light 24-h cycle; dark bar for dark. 
 
 
FIG. 3. Serum prolactin (PRL) levels. CTRL shows the normal PRL levels in the blood. SHAM shows the effects 
of animal handling stress on the PRL levels. BURN shows the effects of the burn injury on the PRL levels. Values 
represent the means ± SEM. Differences appear at 9:30 a.m. CTRL is significantly different from SHAM (P < 
0.05) and from BURN (P < 0.01), and BURN also significantly differs from SHAM (P < 0.05). Values represent 
the means ± SEM. *Differs from CTRL (P < 0.05); **differs from CTRL (P < 0.01 ); 
●
differs from SHAM (P < 




Serum hormone levels after burn injury 
The normal circadian cycle of CS, which peaks early in the dark phase (25), resulted in the lowest level being 
recorded at 9:30 a.m. and the highest at 4 p.m. When the burn injury was performed, CS levels were elevated 10-
fold by 1.5 h (9:30 a.m.) after the injury, reaching a maximum of 600 ng/mL. The serum concentration 
progressively declined to normal levels by 6 h after the burn injury and followed the normal pattern thereafter. 
There was also a stress-induced alteration in CS concentrations in sham-treated animals, but the maximum 
elevation was lower (5-6-fold) and returned to normal concentration after only 4 h (Fig. 2). 
The normal circadian cycle of PRL, resulled in highest levels at 8 a.m. In male rats, PRL normally peaks late in 
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the dark phase (26). Consequently, the sampling schedule would miss the expected peak. Because PRL secretion 
is pulsatile (27). the PRL level in the normal controls at the S a.m. sample was highly variable. PRL secretion 
was dramatically inhibited alter burn injury (below 20 ng/mL) and stayed below control levels for longer than 4 
h after the burn injury. In sham-treated animals, PRL was also temporarily suppressed, but in contrast to the 
burned animals, PRL returned to normal by 4 h after the sham treatment (Fig. 3). 
Neutrophils and Mo/Ma in the jejunum 
Neutrophils and monocyte/macrophage populations in the jejunum were quantified at several time points (day 1: 
12 p.m. and 7 p.m.; day 2: 8 a.m.). This control was thought to be important because invading cells could 
influence the apparent STAT5 quantities in gut protein extracts. Positive and negative controls were used in each 
case. Neutrophil and Mo/Ma positive controls were, respectively, bone marrow and spleen cell protein extracts, 
whereas negative controls were, respectively. CHO D6 cells protein extract and primary antibody-omitted 
Western blotting. Myeloperoxidase levels (neutrophil marker) were similar to the negative control at all times of 
day. Similarly, anti-rat Mo/Ma staining was low at all times of day (maximum 2% of spleen control). Therefore, 
we conclude that invasive cells did not contribute significantly to the quantification of gut STAT5 proleins. 
STAT5 in the jejunum of burn-injured rats 
STAT5 levels in the jejunum of control animals varied among the time points but did not show an organized 
circadian pattern. STAT5 levels were at each time higher in the burned animal than in the sham-treated animals 
(Pig. 4). Analysis of variance showed an overall treatment effect of burn injury (P < 0.01 compared with sham), 
but there was no significant time of day effect. Among the individual sampling limes, only the first time point 
(1.5 h) showed statistical significance. 
There was no evident circadian cycle obtained for phospho-STAT5 al the experimental times examined. 
Considering the binned animal data, the pSTAT5 content was higher than in control animal 8 and 11 h after the 
burn injury. The pattern for the sham-treated animals was similar to the burned animals except at 7 p.m., when 
the burned animals had a higher level of pSTAT5 (Fig. 5). 
Figure 6 shows representative immunoblots for pSTAT5 and STAT5 in samples from mice 11 h after the burn 
injury. 
 
FIG. 4. Gut (jejunum) STAT5 levels. CTRL shows the normal STAT5 pattern in the gut. SHAM shows the effect 
of anesthesia and animal handling on the STAT5 levels. BURN shows the effects of the burn injury on the STAT5 
levels. No evidence of an organized STAT5 circadian cycle was observed in the gut. Values represent the means 
± SEM. Bar: dark-light 24-h cycle; dark bar for dark. *Differs from CTRL (P < 0.05); 
●●
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FIG. 5. Gut (jejunum) phospho-STAT5 levels. CTRL shows the normal pSTAT5 pattern in the gut. SHAM shows 
the effect of anesthesia and animal handling on the pSTAT5 levels. BURN shows the effects of the burn injury on 
the pSTAT5 levels. No evidence of an organized phospho-STAT5 circadian cycle was observed in the gut. BURN 
values significantly differ from CTRL at 4PM (P < 0.01), 7 p.m. (P < 0.05), day 2 8 a.m. (P < 0.01). SHAM 
values significantly differ from CTRL at 4 p.m. (P < 0.05) and 7 p.m. (P < 0.01 ), and from BURN only at 9 a.m. 
(P < 0.05) and 7 p.m. (P < 0.01 ). Values represent the means ± SEM. *Differs from CTRL (P < 0.05); **differs 
from CTRL (P < 0.01); 
●●
differs from SHAM (P < 0.01). 
 
 
FIG. 6. Representative pSTAT5 and STAT5 labeling in Western blotting. Extracts were obtained 11 h after the 





We tested in this article the hypothesis that during the first 24 h after a burn injury, the secretion of PRL and 
glucocorticoids is increased. We also tested whether the resulting hormonal changes could contribute through 
STAT5 to the loss of tissue integrity observed in the post-burn gut. 
The serum concentrations of PRL and CS were measured by RIA at several time points during the first 24 h alter 
burn injury. In our model, CS levels were elevated after the burn injury. Indeed, the results obtained here for CS 
serum levels show a large increase by 90 min after the burn injury and then returning gradually back to normal. 
CS reached the normal circadian pattern by 6 h after the burn injury. The normal circadian pattern continued 
through 48 h aller burn injury (data not shown). The stress control (SHAM-treated animals) showed that the 
response pattern is typical of a stress response but is higher and longer lasting when a burn injury is applied. This 
implies a higher level of stress or other mechanisms acting in parallel. 
Concerning PRL, our model supposed also a rise in serum PRL after burn injury.  However, the results showed a 
decreased PRL level in serum by 90 min which lasted at least 4 h after the burn injury. This result may seem to 
contradict published literature, which has shown that stress causes increased PRL secretion (8). However, data in 
the literature have been mainly concerned with PRL levels from 24 h to several weeks after burn injuries, and 
none have measured PRL levels during the first 24 h after the burn injury. 
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Other classic experiments regarding stress-induced PRL secretion focused on the rapid secretion of stored PRL 
during the first few minutes after stresses such as ether or restraint (28 and references therein). We concerned 
ourselves with PRL levels during the time frame that coincides with changes in GC secretion, i.e., hours rather 
than either minutes or days. This lime frame has special relevance because of the proven interactions between 
PRL and GC signal transduction (12). PRL-R activation in neutrophils triggers elevated superoxide anion 
secretion (29), which is important for the antibacterial response, but which also causes tissue damage (30). 
Consequently, a temporary reduction in PRL secretion after burn trauma may minimize the tissue damage 
resulting from neutrophils released from the bone marrow in response to the injury (31). In human, the GH 
molecule binds to and activates the PRL-R in neutrophils (29). This interaction may explain the observation that 
high serum hGH during the first 6 h after a burn are associated with a poorer patient prognosis (7). 
In a previous study using mice, Neely et al. (32) saw a raise of serum IL-6 levels 8h after burn injury. As for GH, 
high post-burn IL-6 levels are correlated with higher patient mortality (33). GC is known to inhibit IL-6 mRNA 
expression in the rat (34), but IL-6 production is significantly increased by both gut-derived macrophages and 
enterocytes after thermal injury (35). The effects of GH and PRL on IL-6 expression are less clear. GH reduced 
gut bacteria translocation or spreading and hypermetabolic response through IGF-1 stimulation (36, 37). IGF-1 
could thus also be considered as a therapeutic molecule. 
The resulting effects of such interactions could be mediated by STAT5 and STAT5 phosphorylation in the gut. 
STAT5 activity was assessed by quantifying total STAT5 and phosphorylaled STAT5 in total protein extracts 
from the jejunum. 
First, the absence of a well-defined circadian pattern for STAT5 and pSTAT5 seemed to indicate that STAT5 
synthesis and activation in the gut are probably not dependent on one predominant factor (PRL or CS for 
example). This would be consistent with the hypothesis that STAT5 is an integrator of several factors. Also, 
levels of STAT5 were significantly reduced in sham-treated animals and increased in burn-treated animals 1.5 h 
after burn injury. Although STAT5 tended to be higher in the gut of burned animals at all times of the day, the 
values were quite variable in the burned animals. In contrast with CS and PRL, STAT5 does not seem to be 
modified after burn injury in a way typical of a stress response. The levels of phospho-STAT5 were very similar 
in control, sham-treated, and burn-treated animals, except during a period of lime between 8 and 24 h after burn 
injury. At those times, burn injury seems to cause an elevation of pSTAT5 levels above the control levels. This 
may reflect a generally higher level of cytokine stimulation that occurs several hours after the burn but not 
during the initial stress phase. 
These results could be interpreted as follows. By 8 h after burn injury or sham treatment, when CS levels are 
reduced and PRL levels are back to normal, STAT5 phosphorylation is increased. Loss of gut banier integrity 
occurs by 2 h after burns (38), which coincides with a high ratio of CS to PRL, but does not correlate with a 
modified STAT5 phosphorylation level. We conclude that STAT5 activity is unlikely to be an important 
regulator of gut pathology during the first few hours after a burn. 
In conclusion, we showed in male Sprague-Dawley rats first that hormonal response to burn injury during the 
first hours after burn injury is partially typical of a response to stress. We showed a rise of CS levels and a 
reduction of PRL levels in the serum during 4-6 h after burn injury. A link with the immune effects of these 
hormones could suggest that it would be inappropriate to use PRL timing the first hours after burn injury in a 
therapeutic protocol, because it could trigger undesired neutrophil activation in the blood and inflammatory 
processes. We also showed that the changes in STAT5 and phospho-STAT5 are probably not more than minor 
contributors to the burn-induced gut modifications. Nevertheless, closely related factors could be modulated by 
burn injuries. For example, the suppressor of cytokine signaling-3 (SOCS-3) factor, a STAT5 inhibitor, is 
modified post-burn (39) and could exert significant effects on the STAT5 signaling and activity. 
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